BioPharma Credit Dividends

BPCR Stock

0.89 0.01 1.11%

Dividends Paid is likely to drop to about 112 M in 2025. BioPharma Credit's past performance could be the main factor of why investors trade BioPharma Credit PLC stock today. Investors should clearly understand every aspect of the BioPharma Credit dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest BioPharma Credit's dividend schedule and payout information. BioPharma Credit PLC dividends can also provide a clue to the current valuation of BioPharma Credit.

		Last Reported	Projected for Next Year
	Dividends Paid	174.7 M	112 M

One of the primary advantages of investing in dividend-paying companies such as BioPharma Credit is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.

Investing in dividend-paying stocks, such as BioPharma Credit PLC is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in BioPharma Credit must own a stock before its ex-dividend date to receive its next dividend.

BioPharma Credit Expected Dividend Income Per Share

Dividend payment represents part of BioPharma Credit's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in BioPharma Credit. BioPharma Credit's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.

$0.05

Bottom Scenario

0.05

$0.06

Top Scenario

One Year

BioPharma Credit PLC expected dividend income per share adjusted for ongoing price standard deviation

BioPharma Credit Past Distributions to stockholders

	29th of October 2024	0.04
	26th of September 2024	0.02
	31st of July 2024	0.02
	30th of April 2024	0.02
	15th of March 2024	0.03
	5th of January 2024	0.04

Please note, there is a significant difference between BioPharma Credit's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioPharma Credit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioPharma Credit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols:

Apply

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

BioPharma Credit Dividends

BioPharma Credit Expected Dividend Income Per Share

BioPharma Credit Past Distributions to stockholders

Compare Dividends Across Peers

Specify up to 10 symbols:

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY